Research Progress of Traditional Chinese Medicine Based on TGF-β/Smad Signal Pathway in Preventing and Treating Myocardial Fibrosis in Heart Failure
DOI:
https://doi.org/10.53469/jcmp.2024.06(06).13Keywords:
Heart failure, Myocardial fibrosis, TGF-β/Smad, Traditional Chinese medicine, Signal pathway, SummaryAbstract
Heart failure is the terminal stage of cardiovascular disease, and its pathological mechanism is ventricular remodeling. Therefore, the fundamental of preventing and treating heart failure is to inhibit ventricular remodeling. The important link of ventricular remodeling is myocardial fibrosis. It can prevent and cure heart failure by inhibiting the occurrence of myocardial fibrosis. By querying relevant domestic and foreign literatures in recent years, it was found that TGF-β/Smad signaling pathway plays an important role in the development of myocardial fibrosis, it may reduce cell damage through anti-inflammatory, antioxidant stress, anti-apoptosis, etc., Maintaining extracellular matrix stability, alleviate the degree of myocardial fibrosis, Chinese medicine in the prevention and treatment of fibrosis has high efficacy, multi-target, improve long-term prognosis and other advantages. To explore a more accurate target drug for preventing and treating myocardial fibrosis in heart failure, reduce the rate of readmission of patients with heart failure, and provide a greater possibility for promoting the prevention and treatment of myocardial fibrosis in heart failure by traditional Chinese medicine.
References
Guidelines for the rational use of medications in heart failure (2nd ed.) [J]. Chinese Journal of Frontiers of Medicine (Electronic Edition), 2019,11(07): 1-78.
HAO G, WANG X, CHEN Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015[J]. Eur J Heart Fail, 2019,21(11): 1329-1337.
ROGER V L. Epidemiology of Heart Failure: A Contemporary Perspective[J]. Circ Res, 2021,128(10): 1421-1434.
LIGHTHOUSE J K, SMALL E M. Transcriptional control of cardiac fibroblast plasticity[J]. J Mol Cell Cardiol, 2016,91: 52-60.
YEH H W, HSU E C, LEE S S, et al. PSPC1 mediates TGF-beta1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis[J]. Nat Cell Biol, 2018,20(4): 479-491.
FRANGOGIANNIS N G. The role of transforming growth factor (TGF)-beta in the infarcted myocardium[J]. J Thorac Dis, 2017,9(Suppl 1): S52-S63.
HINCK A P, MUELLER T D, SPRINGER T A. Structural Biology and Evolution of the TGF-beta Family[J]. Cold Spring Harb Perspect Biol, 2016,8(12).
DONG X, ZHAO B, IACOB R E, et al. Force interacts with macromolecular structure in activation of TGF-beta[J]. Nature, 2017,542(7639): 55-59.
BATLLE E, MASSAGUE J. Transforming Growth Factor-beta Signaling in Immunity and Cancer[J]. Immunity, 2019,50(4): 924-940.
DERYNCK R, BUDI E H. Specificity, versatility, and control of TGF-beta family signaling[J]. Sci Signal, 2019,12(570).
GU S, FENG X H. TGF-beta signaling in cancer[J]. Acta Biochim Biophys Sin (Shanghai), 2018,50(10): 941-949.
LUO K. Signaling Cross Talk between TGF-beta/Smad and Other Signaling Pathways[J]. Cold Spring Harb Perspect Biol, 2017,9(1).
SEGURA A M, FRAZIER O H, BUJA L M. Fibrosis and heart failure[J]. Heart Fail Rev, 2014,19(2): 173-185.
Feng Xianyong, Luo Xinying. Effects of Riqi Qiangxin Tang combined with conventional western medicines on cardiac function and blood rheology in patients with cardiorenal and renal yang deficiency in chronic heart failure[J]. Journal of Gansu University of Traditional Chinese Medicine, 2020,37(06): 55-58.
Su Hongli, Wu Hao, Li Changhong. Clinical study on the treatment of chronic heart failure in the elderly with Jiawei Siwei Tang[J]. World Journal of Integrative Chinese and Western Medicine, 2019,14(07): 974-977.
FRANGOGIANNIS N G. Transforming growth factor-beta in myocardial disease[J]. Nat Rev Cardiol, 2022,19(7): 435-455.
KUHN T C, KNOBEL J, BURKERT-RETTENMAIER S, et al. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction[J]. Circulation, 2020,141(20): 1628-1644.
ADIARTO S, HEIDEN S, VIGNON-ZELLWEGER N, et al. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy[J]. Life Sci, 2012,91(13-14): 651-657.
SHAH T, QIN S, VASHI M, et al. Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome[J]. Clin Transl Med, 2018,7(1): 19.
XU J G, ZHU S Y, HENG B C, et al. TGF-beta1-induced differentiation of SHED into functional smooth muscle cells[J]. Stem Cell Res Ther, 2017,8(1): 10.
NEVERS T, SALVADOR A M, GRODECKI-PENA A, et al. Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure[J]. Circ Heart Fail, 2015,8(4): 776-787.
LIU X, SHI G P, GUO J. Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling[J]. Front Cell Dev Biol, 2021,9: 659666.
KHALIL H, KANISICAK O, PRASAD V, et al. Fibroblast-specific TGF-beta-Smad2/3 signaling underlies cardiac fibrosis[J]. J Clin Invest, 2017,127(10): 3770-3783.
YANG Li-Na, ZHU Bang-Xian. Compilation and comparison of cardiac disease terminology in ancient and modern Chinese medicine[J]. China Journal of Basic Chinese Medicine, 2020,26(05): 575-576.
Wang Yan, Qin J, Chen Bo. Clinical experience of Prof. Chen Bo in the treatment of chronic heart failure[J]. Guangming Traditional Chinese Medicine, 2023,38(06): 1045-1049.
Ao Zhang, Zhongwen Chai, Mingyang Wang, et al. Chronic heart failure treated by Zhang Junping's methodology of observing the disease mechanism and responding to the four seasons[J]. Journal of Chinese Medicine, 2021,36(12): 2602-2605.
ZHANG Jun-Fang, WEI Cong, WANG Hong-Tao, et al. Exploring the pathogenesis of chronic heart failure from the theory of veins and collaterals[J]. Journal of Traditional Chinese Medicine, 2014,55(13): 1086-1089.
Chu Mei, Tong Xiaolei, Li Shaomin. Diagnostic thinking and diagnostic experience of Li Shaomin in treating heart failure by tonifying the kidney and strengthening the heart[J]. Journal of Chinese Medicine, 2023,35(05): 886-890.
WU Meifang, LU Shichao, ZHANG Junping. Exploration of Chinese medicine diagnosis and treatment ideas of myocardial fibrosis[J]. Shizhen Guomao Guomao, 2015,26(03): 677-679.
WEI Hong, YAN Guoliang, LI Yuehua. A preliminary study on the mechanism of myocardial fibrosis treatment from phlegm and stasis theory[J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2019,42(01): 38-39.
Wang Shengwan, Hu Jingqing, Jiang Lijie, et al. Exploration of possible related molecular biological mechanisms of phlegm-stasis interlude formation[J]. World Science and Technology-Modernization of Traditional Chinese Medicine, 2016,18(05): 805-812.
CHEN Yan, LI Jinlong, LIANG Qianqian, et al. Modern biological basis of "phlegm stasis" in Chinese medicine[J]. World TCM, 2014,9(06): 693-695.
QI Yifei, REN Xuejiao, LOU Lixia, et al. Effects of Fuzheng Huayu capsule on extracellular matrix metabolism in rats with myocardial fibrosis after myocardial infarction[J]. Journal of Traditional Chinese Medicine, 2018,59(07): 607-611.
LIU Jinying, ZHANG Huimin, TIAN Lei, et al. A preliminary study on the theoretical basis of myocardial fibrosis in heart failure caused by "stasis poison"[J]. Chinese Journal of Traditional Chinese Medicine, 2018,33(09): 4027-4030.
WANG Kang, CHANG Liping, YIN Yujie, et al. Discussion on the pathogenesis and clinical treatment of myocardial fibrosis after acute myocardial infarction in Chinese medicine based on the guidance of pulse and collateral theory[J]. Chinese Journal of Experimental Formulas, 2021,27(12): 189-195.
LI Ziru, NI Shihao, DONG Xin, et al. Clinical recommendations for the use of proprietary Chinese medicines in the treatment of heart failure[J]. Chinese Journal of New Drugs, 2023,32(04): 348-356.
WANG Shuchen, QI Fang, CHEN Huijun. Progress on the mechanism of action of Qidanemerosa hebecarpa strong heart capsule in the treatment of chronic heart failure[J]. China TCM Emergencies, 2022,31(11): 2061-2064.
CHENG Z H, GAO Bo. Analysis of 72 cases of refractory heart failure treated with Qi Ling Tang[J]. Electronic Journal of Cardiovascular Disease of Combined Chinese and Western Medicine, 2018,6(03): 139-142.
CAVALERA M, WANG J, FRANGOGIANNIS N G. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities[J]. Transl Res, 2014,164(4): 323-335.
GAO S, ZHAO D, WANG M, et al. Association Between Circulating Oxidized LDL and Atherosclerotic Cardiovascular Disease: A Meta-analysis of Observational Studies[J]. Can J Cardiol, 2017,33(12): 1624-1632.
Luan B, Luan M, Qiu YH. Puerarin activation of Nrf2 pathway attenuates oxidative stress injury in heart failure rats[J]. Modern Preventive Medicine, 2019,46(10): 1852-1856.
Gong Fanying, Du Yuying, Li Jia, et al. Effects of anti-heart failure formula on cardiac function and oxidative stress in patients with chronic heart failure[J]. Journal of Nanjing University of Traditional Chinese Medicine, 2023,39(02): 118-123.
Wang J. Effects of Danhong injection on oxidative stress state and cardiac function in elderly patients with chronic heart failure[J]. Modern Journal of Integrative Chinese and Western Medicine, 2016,25(31): 3443-3445.
HE S, FAN H, SUN B, et al. Tibetan medicine salidroside improves host anti-mycobacterial response by boosting inflammatory cytokine production in zebrafish[J]. Front Pharmacol, 2022,13: 936295.
CHEN P, LIU J, RUAN H, et al. Protective effects of Salidroside on cardiac function in mice with myocardial infarction[J]. Sci Rep, 2019,9(1): 18127.
DIVYA G, PANONNUMMAL R, GUPTA S, et al. Acitretin and aloe-emodin loaded chitin nanogel for the treatment of psoriasis[J]. Eur J Pharm Biopharm, 2016,107: 97-109.
DONG X, ZENG Y, LIU Y, et al. Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics[J]. Phytother Res, 2020,34(2): 270-281.
ZHANG J, AN S J, FU J Q, et al. Mixed Aqueous Extract of Salvia Miltiorrhiza Reduces Blood Pressure through Inhibition of Vascular Remodelling and Oxidative Stress in Spontaneously Hypertensive Rats[J]. Cell Physiol Biochem, 2016,40(1-2): 347-360.
BEDARD K, KRAUSE K H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology[J]. Physiol Rev, 2007,87(1): 245-313.
JIANG F, LIU G S, DUSTING G J, et al. NADPH oxidase-dependent redox signaling in TGF-beta-mediated fibrotic responses[J]. Redox Biol, 2014,2: 267-272.
LIN J, FANG L, LI H, et al. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress[J]. Eur J Pharmacol, 2019,859: 172490.
WEI Y, WU Y, FENG K, et al. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-beta/Smads pathway[J]. J Ethnopharmacol, 2020,249: 112404.
WEI Ling, LI Huiping, LIU Xi, et al. Study on cardiomyocyte apoptosis, myocardial fibrosis and its correlation in rats with chronic heart failure[J]. Southwest Defense Medicine, 2018,28(01): 35-38.
Diao Chenglin, Zhao Zhenyu, Dong Zhenhua, et al. Effects of Zhenwu Tang on cardiomyocyte apoptosis in rats with chronic heart failure[J]. World TCM, 2023,18(10): 1362-1365.
Deng Meng, Guo Li, Zhang Li. Effects of ginseng and sorrel injection on oxidative stress and apoptosis in rats with heart failure[J]. China TCM Emergency, 2017,26(08): 1401-1404.
HUA Xinyu, WANG Xiaolan, KANG Meiqing, et al. Effects of total saponins of Panax ginseng on cardiac function and plasma apoptosis-related factors in patients with chronic heart failure[J]. China TCM Emergencies, 2014,23(12): 2368-2370.
HE G X, XIE J, JIANG H, et al. Effects of Qishen Yiqi Dripping Pills () in Reducing Myocardial Injury and Preserving Microvascular Function in Patients Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study[J]. Chin J Integr Med, 2018,24(3): 193-199.
Zuo Lihua, Zhou Lin, Zhang Xiaojian, et al. Quality evaluation study of Astragalus Ginseng Yiqi Drops Pills by UHPLC-Q-Orbitrap HRMS combined with principal component analysis[J]. Chinese Journal of Hospital Pharmacy, 2019,39(08): 805-810.
WANG L, WANG L, ZHOU X, et al. Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis[J]. Med Sci Monit, 2019,25: 2435-2444.
YANG Q, CAO Y. [Study on mechanisms and myocardial protective effect of Qishen Yiqi dropping pills on rats with myocardial infarction].[J]. Zhonghua wei zhong bing ji jiu yi xue, 2017,29(6).
LIU Zhongyong, LI Lin, FANG Jia. Effects of Zhenwu Tang on ventricular remodeling and cardiomyocyte apoptosis and fibrosis in rats with heart failure model[J]. Journal of Traditional Chinese Medicine, 2017,58(14): 1218-1223.
LI L, FANG H, YU Y H, et al. Liquiritigenin attenuates isoprenaline‑induced myocardial fibrosis in mice through the TGF‑beta1/Smad2 and AKT/ERK signaling pathways[J]. Mol Med Rep, 2021,24(4).
SUETOMI T, MIYAMOTO S, BROWN J H. Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling[J]. Am J Physiol Heart Circ Physiol, 2019,317(5): H877-H890.
ANZAI T. Inflammatory Mechanisms of Cardiovascular Remodeling[J]. Circ J, 2018,82(3): 629-635.
Shan Ying, Fan Weihun, Qi Wenhang, et al. Clinical study on the treatment of stable angina pectoris in the elderly with injectable danshen polyphenate[J]. Chinese Journal of Geriatric Cardiovascular Disease, 2013,15(02): 135-138.
QIU H, LIU W, LAN T, et al. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-beta1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats[J]. Phytomedicine, 2018,51: 255-265.
LIU Q, WU H, WANG J, et al. Effects of Shenmai injection on the values of CO, SV, and EF in patients undergoing off-pump coronary artery bypass graft: A randomized, clinical trial[J]. Medicine (Baltimore), 2018,97(10): e85.
ZHAO Di, ZHAO Tim, ZHAO Zhuo, et al. Effects of Shengwei San on myocardial remodeling and TGF-β1/Smad3 signaling pathway in heart failure rats[J]. China TCM Emergencies, 2021,30(12): 2099-2103.
Huang Xianna, Huang Ling, Luo Hongbo. Study on the interventional effect of tonifying yang and returning five soup on myocardial remodeling in heart failure rats based on TGF-β1/Smads pathway[J]. Chinese Medicine Pharmacology and Clinics, 2019,35(05): 15-20.
WANG T, JIANG X, RUAN Y, et al. Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction[J]. Bioengineered, 2022,13(5): 13767-13783.
CHEN H, SONG H, LIU X, et al. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-beta/Smads and MAPKs signaling activated fibrosis[J]. Biomed Pharmacother, 2017,95: 461-468.
Jiao M, Zhong HY, Chen KY, et al. Quercetin ameliorates myocardial fibrosis through TGF β1/Smad3 signaling pathway in rats with chronic heart failure[J]. Advances in Anatomical Sciences, 2020,26(04): 391-395.
YANG J, WANG B, LI N, et al. Salvia miltiorrhiza and Carthamus tinctorius Extract Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction by Epigenetically Inhibiting Smad3 Expression[J]. Evid Based Complement Alternat Med, 2019,2019: 6479136.
SOUZA B, SILVA D N, CARVALHO R H, et al. Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy[J]. Am J Pathol, 2017,187(5): 1134-1146.
LI Qingmin, QU Wulin, CHEN Bojun. Inhibitory effect of dendrobium ironpierre on myocardial fibrosis in rats with heart failure and heart qi deficiency after ischemia-reperfusion[J]. Chinese Journal of Experimental Formulas, 2019,25(15): 83-88.
XU Yini, ZHAO Linglu, XIAO Yijia, et al. Mechanism of inhibition of TGF-β_1-induced proliferation and transformation of rat cardiac fibroblasts by oxidized ginsengine[J]. Shandong Medicine, 2018,58(01): 30-33.
JIANG Zhihu, MA Jing, WANG Xiaodong, et al. Protective effects of oxidized ginseng alkaloids on myocardial injury in septic shock rats via TGF-β1/Smads signaling pathway[J]. Hebei Medicine, 2022,44(23): 3554-3558.
WONG C, FALKENHAM A, MYERS T, et al. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-beta signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis[J]. J Renin Angiotensin Aldosterone Syst, 2018,19(1): 1605484098.
YANG F, HUANG X R, CHUNG A C, et al. Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition[J]. J Pathol, 2010,221(4): 390-401.
HOSEINI A, NAMAZI G, FARROKHIAN A, et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease[J]. Food Funct, 2019,10(9): 6042-6051.
HU L F, LAN H R, LI X M, et al. A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities[J]. Oxid Med Cell Longev, 2021,2021: 2951697.
SONG J, HUANG Y, ZHENG W, et al. Resveratrol reduces intracellular reactive oxygen species levels by inducing autophagy through the AMPK-mTOR pathway[J]. Front Med, 2018,12(6): 697-706.
Zhuo SZ, Liu Yi, Li Na, et al. Resveratrol inhibits Ang II-induced type I/III collagen synthesis in cardiac fibroblasts via TGF-β1/Smad3 signaling pathway[J]. Journal of Xi'an Jiaotong University (Medical Edition), 2018,39(04): 525-529.
TAN Jianfeng, WEN Wei, HUANG Huacong, et al. Role of TGF-β_1/Smad signaling pathway in the inhibition of AngⅡ-induced cardiomyocyte hypertrophy by ginseng yangrong tang[J]. China Medical Guide, 2020,18(15): 1-3.
ZHANG Yonghua, HE Jianxin, YAN Chunlu, et al. Study on the protective mechanism of Angelica sinensis blood replenishing soup on Ang Ⅱ induced hypertrophic cardiomyocytes via TGF-β1/Smad2 pathway[J]. Chinese Medicine Pharmacology and Clinics, 2018,34(02): 9-13.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ximei Zhu, Bo Yang, Yajun Lu, Meng Zhang, Yina Shi, Jinfeng Chen
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
